SOL Capital Management CO Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

SOL Capital Management CO cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 30,884 shares of the exchange traded fund’s stock after selling 1,221 shares during the quarter. SOL Capital Management CO’s holdings in SPDR S&P Biotech ETF were worth $2,781,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the stock. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd bought a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $141,284,000. Assetmark Inc. raised its holdings in SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after buying an additional 588,489 shares during the last quarter. Sivik Global Healthcare LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the third quarter worth about $29,640,000. Finally, Mirae Asset Securities USA Inc. increased its holdings in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after purchasing an additional 300,000 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $93.54 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The stock has a market cap of $7.13 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock has a 50 day simple moving average of $93.31 and a two-hundred day simple moving average of $96.77.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.